Appian Way Asset Management LP Buys 34,990 Shares of DarioHealth Corp. (NASDAQ:DRIO)

Appian Way Asset Management LP lifted its stake in shares of DarioHealth Corp. (NASDAQ:DRIO) by 2.5% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,410,870 shares of the company’s stock after purchasing an additional 34,990 shares during the quarter. DarioHealth accounts for about 0.4% of Appian Way Asset Management LP’s portfolio, making the stock its 28th largest position. Appian Way Asset Management LP’s holdings in DarioHealth were worth $1,580,000 as of its most recent filing with the Securities and Exchange Commission.

Separately, DLK Investment Management LLC grew its holdings in shares of DarioHealth by 71.6% during the 3rd quarter. DLK Investment Management LLC now owns 100,550 shares of the company’s stock valued at $113,000 after purchasing an additional 41,943 shares during the last quarter. Institutional investors and hedge funds own 33.39% of the company’s stock.

DarioHealth Trading Up 9.6 %

DRIO opened at $0.79 on Friday. DarioHealth Corp. has a fifty-two week low of $0.67 and a fifty-two week high of $2.60. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.57 and a quick ratio of 1.32. The firm has a market capitalization of $26.90 million, a price-to-earnings ratio of -0.84 and a beta of 1.51. The company’s 50 day moving average price is $0.93 and its two-hundred day moving average price is $1.08.

DarioHealth Profile

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.